Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergerot, I.
Right arrow Articles by Delovitch, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergerot, I.
Right arrow Articles by Delovitch, T. L.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 48, Issue 9 1720-1729, Copyright © 1999 by American Diabetes Association

ARTICLES

Insulin B-chain reactive CD4+ regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells

I Bergerot, GA Arreaza, MJ Cameron, MD Burdick, RM Strieter, SW Chensue, S Chakrabarti and TL Delovitch
Autoimmunity/Diabetes Group, The John P. Robarts Research Institute, London, Ontario, Canada.

The mechanism of protection from type 1 diabetes conferred by regulatory T-cells induced by oral insulin treatment of NOD mice is not well understood. We demonstrate that oral insulin feeding of NOD mice induces the function of insulin B-chain reactive CD4+ regulatory T-cells, which compete with diabetogenic effector T-cells for the recognition of insulin in NOD.Scid recipient mice. These effector T-cells become deprived of interleukin (IL)-2 and interferon (IFN)-gamma and are unable to expand and migrate to the pancreas. Type 1 diabetes-protective splenic regulatory T-cells secrete relatively little transforming growth factor (TGF)-beta1, suggesting that TGF-beta may not contribute to the inactivation of effector T-cells in NOD.Scid recipients. The observed preferential infiltration of insulin-reactive regulatory T-cells rather than effector T-cells in the pancreas results in a nondestructive insulitis that correlates with an increased intrapancreatic expression of macrophage inflammatory protein-1beta. Thus, oral insulin therapy overcomes a deficiency in regulatory T-cells and protects against type 1 diabetes by inducing insulin B-chain reactive regulatory T-cells to block cytokine secretion and migration of diabetogenic effector T-cells to the pancreas. Our data emphasize that continuous oral insulin feeding over a prolonged period is required to prevent type 1 diabetes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
M. G. Levisetti, A. Suri, S. J. Petzold, and E. R. Unanue
The Insulin-Specific T Cells of Nonobese Diabetic Mice Recognize a Weak MHC-Binding Segment in More Than One Form
J. Immunol., May 15, 2007; 178(10): 6051 - 6057.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Meagher, G. Arreaza, A. Peters, C. A. Strathdee, P. A. Gilbert, Q.-S. Mi, P. Santamaria, G. A. Dekaban, and T. L. Delovitch
CCL4 Protects From Type 1 Diabetes by Altering Islet {beta}-Cell-Targeted Inflammatory Responses
Diabetes, March 1, 2007; 56(3): 809 - 817.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. Bruder, A. M. Westendorf, R. Geffers, A. D. Gruber, M. Gereke, R. I. Enelow, and J. Buer
CD4 T Lymphocyte-mediated Lung Disease: Steady State between Pathological and Tolerogenic Immune Reactions
Am. J. Respir. Crit. Care Med., December 1, 2004; 170(11): 1145 - 1152.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Q.-S. Mi, D. Ly, P. Zucker, M. McGarry, and T. L. Delovitch
Interleukin-4 but not Interleukin-10 Protects Against Spontaneous and Recurrent Type 1 Diabetes by Activated CD1d-Restricted Invariant Natural Killer T-Cells
Diabetes, May 1, 2004; 53(5): 1303 - 1310.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Oikawa, A. Shimada, A. Kasuga, J. Morimoto, T. Osaki, H. Tahara, T. Miyazaki, F. Tashiro, E. Yamato, J.-i. Miyazaki, et al.
Systemic Administration of IL-18 Promotes Diabetes Development in Young Nonobese Diabetic Mice
J. Immunol., December 1, 2003; 171(11): 5865 - 5875.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. E. Pauza, A. Nguyen, T. Wolfe, I-C. Ho, L. H. Glimcher, M. von Herrath, and D. Lo
Variable Effects of Transgenic c-Maf on Autoimmune Diabetes
Diabetes, January 1, 2001; 50(1): 39 - 46.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
A. G.S. van Halteren, B. Mosselman, B. O. Roep, W. van Eden, A. Cooke, G. Kraal, and M. H. M. Wauben
T Cell Reactivity to Heat Shock Protein 60 in Diabetes-Susceptible and Genetically Protected Nonobese Diabetic Mice Is Associated with a Protective Cytokine Profile
J. Immunol., November 15, 2000; 165(10): 5544 - 5551.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. J. Cameron, G. A. Arreaza, M. Grattan, C. Meagher, S. Sharif, M. D. Burdick, R. M. Strieter, D. N. Cook, and T. L. Delovitch
Differential Expression of CC Chemokines and the CCR5 Receptor in the Pancreas Is Associated with Progression to Type I Diabetes
J. Immunol., July 15, 2000; 165(2): 1102 - 1110.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1999 by the American Diabetes Association.